Search

Our objectives were to determine the reporting of symptoms, the medical outcome and the work status of meat plant workers diagnosed with clinical carpal tunnel syndrome (CTS). Forty-seven cases of CTS were identified from a previously reported study, and were matched by age, gender and hand use. Cases and controls were followed up for 24 months. The Provincial Workers' Compensation Board and company health records were used to determine the reporting of symptoms, interventions and work status. Thirty-one study cases and all control cases were followed for the full 24 months (16 study cases were lost to follow-up). In total, 12 cases reported symptoms of CTS during the 24 months (eight study cases and four controls). Of the eight study cases, one required surgical release of the carpal tunnel. After a period of work modification, five of the eight study cases returned to regular duty and the remainder were placed on permanent job restrictions. Of the four controls, one subject had a surgical release and returned to regular work, two subjects' jobs were permanently modified, and the fourth returned to regular duty. Occupation-related CTS in meat packers appears to be transient and responsive to conservative measures, with a surgical rate comparable to other occupations.

OBJECTIVES: To determine prevalence and incidence of carpal tunnel syndrome (CTS) in a modern meat packing plant. The secondary objective was to explore the relation between ethnicity and CTS. METHODS: Six hundred and sixty five workers were interviewed and examined to find the prevalence of CTS. Subsequently, 421 workers without CTS were followed up and examined at a median interval of 253 days; of those, 333 remained without CTS and were again examined at a median interval of 148 days. RESULTS: The prevalence and incidence of CTS was 21% and 11/100 person-years, respectively. The incidence for Asian mixed, white, and other ethnicities was 12.0, 12.2, and 7.2 cases/100 person- years, respectively. The observed incidence for men and women was 9.7 and 18.4 cases/100 person-years, respectively. This difference was not quite significant (p = 0.068) with an estimated relative risk (women v men) of 1.9 (95% confidence interval (95% CI) 0.9 to 3.8). The interaction between sex and use of tools was significant (p = 0.04), however, although the relative risk for CTS in women who used tools was 4.2 the numbers were small and not significant. The relative risk for men who used tools was 0.64 and not significant. The percentage of incident cases with comorbid disease was only 6.3% (3/47). CONCLUSIONS: The prevalence and incidence of CTS in this workforce were higher than in the general population. However, the prevalence of CTS in this modern, mechanised plant was not significantly different from that reported in older plants. No relation was found between ethnicity, age, body mass index, and CTS for either prevalence or incidence. Comorbid disease among the cases of CTS is significantly less than that found in other industry.

Sport-related injury is a common problem seen in the emergency department of Canadian hospitals. The mechanism of injury is essential information in making an accurate diagnosis. The motivation of the athlete is an important factor in arranging appropriate follow-up and counselling for return to activity. This article addresses diagnostic and management considerations for shoulder injury, acute knee injury, concussion, compartment syndrome, and stress fracture.

The purpose of the present study was to derive a regression equation relating variables obtained from a series of noninvasive functional tests in a normal subject population to the fiber type distribution of vastus lateralis muscle (VL) determined using muscle biopsy. All functional tests were designed to distinguish between basic properties of Type II fibers (fast twitch fibers) and Type I fibers (slow twitch fibers) and included assessment of peak torque, power output at nine different angular velocities (60 degrees.s-1 to 300 degrees.s-1), as well as a fatigue test consisting of 60 consecutive contractions at 90 degrees.s-1 to establish fatigue resistance of the knee extensor muscles. Using a stepwise multiple regression procedure, relative torque after 53-55 contractions (T55) in the fatigue test and power output at an angular velocity of 280 degrees.s-1 normalized for fat free mass of the thigh (FFMT) were the best predictors for fiber type distribution, explaining 51.8% of the variance in the proportion of Type II fibers in VL. No other measured variable met entering criteria. Subgroup analyses revealed a higher peak torque/FFMT, higher power/FFMT values at angular velocities of 200 degrees.s-1 and higher, and lower relative torque beyond 30 contractions in the fatigue test for the fast twitch group, FTG (subjects with > 60% Type II fibers, N = 8) as compared with the STG (subjects with < 45% Type II fibers, N = 9). Results from the present study suggest that two simple functional tests on a Cybex dynamometer yield reasonable estimates of the fiber type distribution in VL.

A variety of construction methods can be used to form high-density printed-circuit boards. The electrical and mechanical requirements of a design strongly influence the choice of process used to produce the finished product. The introduction of physically large high-density boards required the development of many new processes, several of which are critical to the electrical performance of the composite. In this paper the process sequence employed in the fabrication of the 3081 high-density board is described, with particular emphasis on the selection of the critical processes used in its manufacture. The 3081 registration system is also discussed, and a new method for merging through-hole location data with the data representing the location of the conducting layers is presented.

Salbutamol and treadmill performance in non-atopic athletes. Med. Sci. Sports Exerc., Vol. 15, No. 6, pp. 520-522, 1983. Nineteen aerobic, non-atopic, athletes (10 females, 9 males) were studied in a double-blind fashion to determine the effect of a therapeutic dosage of salbutamol on pulmonary function, oxygen consumption (VO2max), heart rate (HR), and anaerobic threshold (AT). A placebo and salbutamol (in aerosol form) were administered in a dosage of two puffs four times per day. Forced vital capacity (FVC), FEV1.0, and mid-maximal expiratory flow were assessed prior to a maximal treadmill run, and at 5, 10, and 15 min of recovery. Resting and maximal HR, VO2max, AT, and VE were determined prior to and immediately after the 1-wk experimental period. Pre-test results showed no evidence of airway obstruction in any athlete. There was no significant change in any pulmonary function variable as a result of salbutamol administration. Maximal oxygen consumption showed a slight, nonsignificant (P greater than 0.05) decrease in both the salbutamol and placebo groups. There was also a similar nonsignificant decrease in pulmonary function in both groups. Resting and maximal HR and AT were unchanged. These results indicate that therapeutic administration of a selective beta-2 agonist does not affect pulmonary function or performance-related variables in non-atopic elite athletes.

Salbutamol and treadmill performance in non-atopic athletes. Med. Sci. Sports Exerc., Vol. 15, No. 6, pp. 520-522, 1983. Nineteen aerobic, non-atopic, athletes (10 females, 9 males) were studied in a double-blind fashion to determine the effect of a therapeutic dosage of salbutamol on pulmonary function, oxygen consumption (VO2max), heart rate (HR), and anaerobic threshold (AT). A placebo and salbutamol (in aerosol form) were administered in a dosage of two puffs four times per day. Forced vital capacity (FVC), FEV1.0, and mid-maximal expiratory flow were assessed prior to a maximal treadmill run, and at 5, 10, and 15 min of recovery. Resting and maximal HR, VO2max, AT, and VE were determined prior to and immediately after the 1-wk experimental period. Pre-test results showed no evidence of airway obstruction in any athlete. There was no significant change in any pulmonary function variable as a result of salbutamol administration. Maximal oxygen consumption showed a slight, nonsignificant (P greater than 0.05) decrease in both the salbutamol and placebo groups. There was also a similar nonsignificant decrease in pulmonary function in both groups. Resting and maximal HR and AT were unchanged. These results indicate that therapeutic administration of a selective beta-2 agonist does not affect pulmonary function or performance-related variables in non-atopic elite athletes.